Skip to content

apotheek Schyvens: what changed

BE 0404.191.575NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€28,940
2024 · €30,467-€1,527
Equity
€382,588
2024 · €386,205-€3,616
Cash
€181,489
2024 · €199,512-€18,024
Balance sheet total
€1.2m
2024 · €1.1m+€80,619

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€39,155

    up €39,155 (+22.0%), from €178,011 to €217,167

    of which Trade receivables: +€46,658

  • Stocks and contracts +€33,440

    up €33,440 (+21.5%), from €155,498 to €188,939

  • Tangible fixed assets +€25,212

    up €25,212 (+4.8%), from €530,384 to €555,595

    of which Furniture and vehicles: +€38,909

  • Cash -€18,024

    down €18,024 (-9.0%), from €199,512 to €181,489

    mainly Investment in fixed assets (net) (-€61,392) and Receivables within one year (-€39,155)

Equity and liabilities
  • Other debts +€30,659

    up €30,659 (+16.3%), from €188,310 to €218,969

  • Trade debts +€28,148

    up €28,148 (+21.9%), from €128,696 to €156,844

  • Current portion of long-term debt +€11,816

    up €11,816 (+37.3%), from €31,693 to €43,509

Income statement
  • Gross operating margin +€27,647

    up €27,647 (+15.1%), from €183,321 to €210,968

  • Staff costs +€24,852

    up €24,852 (+28.8%), from €86,358 to €111,210

  • Depreciation +€2,852

    up €2,852 (+8.4%), from €34,139 to €36,991

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €30,467
Gross operating margin +€27,647
Staff costs -€24,852
Depreciation -€2,852
Other operating charges +€418
Financial income -€400
Financial charges -€545
Taxes -€943
Result 2025 €28,940
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€63,535
Investment -€61,501
Financing -€20,058
Cash 2024 €199,512
Net result for the year +€28,940
Depreciation +€36,991
Stocks and contracts -€33,440
Receivables within one year -€39,155
Deferred charges and accrued income -€1,537
Trade debts +€28,148
Tax, wage and social debts +€9,853
Other debts +€30,659
Accrued charges and deferred income +€3,077
Investment in fixed assets (net) -€61,392
Current investments -€109
Debts after one year +€682
Current portion of long-term debt +€11,816
Contributions, distributions and other -€32,556
Cash 2025 €181,489
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,098,930 €1,179,549 +€80,619 +7.3%
Fixed assets 21/28 €531,930 €556,331 +€24,401 +4.6%
Intangible fixed assets 21 €1,546 €735 -€811 -52.4%
Tangible fixed assets 22/27 €530,384 €555,595 +€25,212 +4.8%
Land and buildings 22 €497,522 €479,860 -€17,662 -3.6%
Plant, machinery and equipment 23 €11,059 €15,023 +€3,964 +35.8%
Furniture and vehicles 24 €21,803 €60,712 +€38,909 +178%
Current assets 29/58 €567,000 €623,218 +€56,218 +9.9%
Stocks and contracts in progress 3 €155,498 €188,939 +€33,440 +21.5%
Stocks 30/36 €155,498 €188,939 +€33,440 +21.5%
Amounts receivable within one year 40/41 €178,011 €217,167 +€39,155 +22.0%
Trade receivables 40 €154,219 €200,877 +€46,658 +30.3%
Other amounts receivable 41 €23,792 €16,290 -€7,503 -31.5%
Current investments 50/53 €25,965 €26,074 +€109 +0.4%
Cash at bank and in hand 54/58 €199,512 €181,489 -€18,024 -9.0%
Deferred charges and accrued income 490/1 €8,013 €9,550 +€1,537 +19.2%
Total equity and liabilities 10/49 €1,098,930 €1,179,549 +€80,619 +7.3%
Equity 10/15 €386,205 €382,588 -€3,616 -0.9%
Contributions 10/11 €222,000 €222,000 = 0.0%
Reserves 13 €164,205 €160,588 -€3,616 -2.2%
Tax-exempt reserves 132 €3,616 - -€3,616
Distributable reserves 133 €160,588 €160,588 = 0.0%
Amounts payable 17/49 €712,725 €796,960 +€84,235 +11.8%
Amounts payable after more than one year 17 €355,509 €356,191 +€682 +0.2%
Financial debts 170/4 €355,509 €356,191 +€682 +0.2%
Amounts payable within one year 42/48 €352,567 €433,044 +€80,476 +22.8%
Current portion of amounts payable after more than one year 42 €31,693 €43,509 +€11,816 +37.3%
Trade debts 44 €128,696 €156,844 +€28,148 +21.9%
Suppliers 440/4 €128,696 €156,844 +€28,148 +21.9%
Taxes, remuneration and social security 45 €3,869 €13,722 +€9,853 +255%
Taxes 450/3 - €303 +€303
Remuneration and social security 454/9 €3,869 €13,418 +€9,550 +247%
Other amounts payable 47/48 €188,310 €218,969 +€30,659 +16.3%
Accrued charges and deferred income 492/3 €4,649 €7,726 +€3,077 +66.2%
Remuneration, social security and pensions 62 €86,358 €111,210 +€24,852 +28.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €34,139 €36,991 +€2,852 +8.4%
Other operating charges 640/8 €3,942 €3,524 -€418 -10.6%
Gross operating margin 9900 €183,321 €210,968 +€27,647 +15.1%
Operating profit (loss) 9901 €58,882 €59,243 +€361 +0.6%
Financial income 75/76B €2,326 €1,926 -€400 -17.2%
Recurring financial income 75 €2,326 €1,926 -€400 -17.2%
Financial charges 65/66B €19,535 €20,080 +€545 +2.8%
Recurring financial charges 65 €19,535 €20,080 +€545 +2.8%
Profit (loss) for the period before taxes 9903 €41,673 €41,089 -€584 -1.4%
Income taxes 67/77 €11,206 €12,149 +€943 +8.4%
Profit (loss) for the period 9904 €30,467 €28,940 -€1,527 -5.0%
Transfer from tax-exempt reserves 789 - €3,616 +€3,616
Profit (loss) for the period to be appropriated 9905 €30,467 €32,556 +€2,089 +6.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€326,716 to €381,031

Midpoint €349,347 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €381,853
Capitalised earnings €271,579 to €380,210
Indication €326,716 to €381,031

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€382,588
Intangible fixed assets (21)
-€735
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€381,853

Capitalised earnings

net result for the year (9904)
2025
€28,940
2024
€30,467
2023
€54,656
2022
€50,474
2021
€90,825
Average result
€38,021
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€271,579 / €316,842 / €380,210

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.